Johnson & Johnson (NYSE:JNJ) is a global healthcare company set to report Q4 2024 earnings on Jan. 22, 2025. Analysts predict an EPS of $2.29 and quarterly revenue of $22.45 billion.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson
